In a research note, Barclays analyst Carole Madjo has maintained his recommendation on the stock with a Neutral rating. The target price has been revised upwards and is now set at EUR 825, compared.
Already positive, the research from Barclays and its analyst Carole Madjo still consider the stock as a Buy opportunity. The target price is unchanged at CHF 155.